Home › Trial NCT00085488
Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma
- Trial IDNCT00085488
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorDartmouth-Hitchcock Medical Center
- Enrollment—
- Start date2004-02
- ConditionsMelanoma (Skin)
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.